Asabys Partners — Full Portfolio

SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.

BiotechDeep TechDigital HealthBarcelona, ES

Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)

Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalCriteria Bio VenturesNew Enterprise Associates (NEA)+2 more

Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases.

BiotechHealthtech

Laurent Nguyen(CEO)inPablo Villoslada(CSO)inRossella Medori(CMO)inPaul Bikard(CFO)in

Co-investorsAliath BioventuresKinled Holding

Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.

BiotechHealthtechMedical DevicesAntwerp, BE

Tim Knotnerus(Chief Executive Officer)

Co-investorsEQT Life SciencesAdBio partnersAndera PartnersCanaan PartnersPontifax Venture CapitalV-Bio Ventures+1 more

ALLOX develops an AI-enabled platform that uses high-throughput genomics and machine learning to discover biophysical parameters governing protein function for drug discovery.

AI & Machine LearningBiotechDeep TechBarcelona, ES

XRHealth provides telehealth therapy delivered at home using FDA-registered VR/AR headsets, mobile apps, wearables, and prescription digital therapeutics (such as Stanza), combined with licensed clinicians.

Digital HealthHealthtechMedical Devices

Co-investorsBStartupShip2B

Anaconda Biomed develops next-generation endovascular access and protection devices.

BiotechHardwareHealthtechMedical DevicesBarcelona, ES

Trent Reutiman(CEO)Hendrik Lambert(Vice-President of Clinical & Regulatory Affairs)Dr. Iñaki GalveMaria Jose AlonsoJordi Cardona

Co-investorsYsios CapitalEuropean Investment BankInnogest Capital

Augustine Therapeutics is a biotech company developing HDAC6-targeted therapies for peripheral neuropathies such as Charcot-Marie-Tooth disease and chemotherapy-induced peripheral neuropathy, as well as neurodegenerative disorders like ALS.

BiotechMedical Devices

Co-investorsAdBio partnersJeito CapitalNovo HoldingsPMVV-Bio Ventures

HealthtechTrowbridge

Stanley Lapidus(Director)Andrew Goldman(Director)Anna Dixon(Executive Officer)Martin Munchbach(Director)Jihua Wang(Director)Joachim Rothe(Director)

Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.

Medical Devices

Co-investorsColumbus Venture Partners

Valuat provides software for managing investment operations, serving fund managers, investors, and founders.

FintechSaaS

Co-investorsNazca Capital S.G.E.I.C,Swanlaab Venture Factory

Co-investorsSofinnova Partners

Gradient develops the Gradient Denervation System, a minimally invasive, ultrasound-based catheter platform that ablates nerves around the pulmonary artery (pulmonary artery denervation) to treat patients with pulmonary hypertension, including those with pulmonary hypertension due to left heart disease.

HealthtechMedical Devices

InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients.

BiotechDigital HealthMedical Devices

Prof Rob E. Coleman(Chairman)

Co-investorsCriteria Bio VenturesYsios CapitalAlta Life Sciences

INBRAIN Neuroelectronics develops graphene-based brain-computer therapeutics that combine neural signal decoding with AI to enable precision, adaptive treatments for neurological disorders.

AI & Machine LearningDeep TechMedical DevicesBarcelona, ES

Carolina Aguilar(CEO & Co-Founder)Kostas Kostarelos(Chair of the Vision Board & Co-Founder)Antòn Guimerà(Co-founder)Jerome Crocco(COO)Jurriaan Bakker(CTO)Eduard Ros(Interim CFO)

Co-investorsBStartupVsquared VenturesAliath Bioventuresimec.xpand

Koa Health develops a unified digital mental health platform that delivers evidence-based treatment programs and clinical interventions.

Digital HealthHealthtechMental Health

Oliver Harrison(Chief Executive Officer)

Co-investorsBeresford VenturesCREAS IMPACTO GLOBAL SGEICMundi VenturesWessel Management

Medasense develops a noninvasive sensor platform and AI technology for objective pain measurement, helping clinicians personalize pain management and avoid overmedication.

AI & Machine LearningDigital HealthHealthtechMedical DevicesRamat Gan, IL

Galit Zuckerman-Stark(Founder and CEO)

Co-investorsOTV

Mediktor is an AI-powered healthcare chatbot platform that enables patients to assess symptoms and receive preliminary guidance through natural language conversations.

AI & Machine LearningDigital HealthHealthtechBarcelona, ES

Oscar García-Esquirol(Co-founder / Medical Director)Cristian Pascual(Founder)Dr. Oscar García-Esquirol(Founder)Roger Forcada(CTO)

binx health develops FDA-cleared, CLIA-waived point-of-care diagnostic testing for chlamydia and gonorrhea in male and female patients, delivering central-lab-quality results in about thirty minutes so patients can test, get diagnosed, and receive treatment in one visit.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsOrbiMed

Nuage develops drug discovery technology targeting intrinsically disordered proteins in cancer, focusing on oncogenic transcription factors previously inaccessible to conventional drug discovery approaches.

AI & Machine LearningBiotechDeep Tech

Co-investorsBStartupSofinnova Partners

Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.

BiotechHealthtechMedical Devices

Co-investorsFund+KorysMérieux Equity PartnersYsios CapitalAlta Life SciencesBpifrance+2 more

Orikine Bio develops precision-engineered bi-specific cytokine therapies ("Foldikines") that reprogram immune signaling to treat severe autoimmune and inflammatory diseases.

BiotechDeep TechHealthtechBarcelona, ES

BoardLarry Edwards(Chairman of the Board)

Co-investorsAdBio partners

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials.

BiotechDeep TechHealthtechMedical DevicesBarcelona, ES

Dr. Laura Soucek(Co-founder and CEO)Dr. Marie-Eve Beaulieu(Co-founder)Laura Soucek(Co-founder & CSO (former CEO))

Co-investorsAurora ScienceInvivo Capital Partners

Qida provides in-home care services for elderly and dependent people in Spain, matching families with professional caregivers on a flexible basis (from one hour a week to live-in 24/7 care) with ongoing supervision by psychologists or social workers.

Digital HealthHealthtechLongevitySabadell, ES

Oriol Fuertes Cabassa(Founder)in

Co-investorsBStartupCREAS IMPACTO GLOBAL SGEICKibo VenturesMundi VenturesShip2BEndeavor Catalyst+2 more

Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies.

AI & Machine LearningHealthtechMedical Devices

Co-investorsAdara VenturesAmadeus Capital PartnersLifeX VenturesAPEX VenturesColumbus Venture PartnersGoHub Ventures

Sidekick Health develops a digital health platform for multi-chronic condition management and personalized care experiences, delivering patient education and lifestyle support for conditions such as IBD, rheumatoid arthritis, and dermatological disease.

Digital HealthHealthtechWellness & Fitness

Co-investorsFrumtak Ventures

XR therapeutics platform company that merged with Amelia Virtual Care.

Co-investors20/20 HealthCare Partners LLCBridges IsraelFlying Tiger Capital